The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection.
about
Evolutionary conflicts between viruses and restriction factors shape immunitySuppression of APOBEC3-mediated restriction of HIV-1 by VifStructural Insights into HIV-1 Vif-APOBEC3F InteractionLess is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selectionThe Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from MonkeysThe HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinantsThe effect of species representation on the detection of positive selection in primate gene data sets.HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6APOBEC3DE Inhibits LINE-1 Retrotransposition by Interacting with ORF1p and Influencing LINE Reverse Transcriptase Activity.Retroelements versus APOBEC3 family members: No great escape from the magnificent sevenNon-human Primate Schlafen11 Inhibits Production of Both Host and Viral ProteinsA cross-species view on virusesMolecular reconstruction of extinct LINE-1 elements and their interaction with nonautonomous elements.APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.Host restriction factors in retroviral infection: promises in virus-host interaction.Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 ReplicationRole of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution.Gene loss and adaptation to hominids underlie the ancient origin of HIV-1.The KT Jeang Retrovirology prize 2017: Michael Emerman.Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
P2860
Q27022032-4076DB6D-E32E-4073-BF0F-2D3634E467A7Q27025150-18AA68F7-FE44-4C42-A40B-D6CE74FE9E5EQ27321018-9D121F92-CB2D-4275-BC50-9450E342EDF7Q28648488-215D42DD-7858-4397-9566-253A8596073EQ30379417-DA22E97F-924B-42D8-B8C8-0C91F6EF818DQ30431054-1352228E-AE66-463D-8262-D771976B6E16Q34059564-D4A2E38E-D028-4E27-8124-E4DC555542EDQ35232354-7F1041FD-D3DC-4B6F-8867-50BD2460B04FQ35826918-5B372E77-94CC-4158-B377-9584B8271498Q36080115-9FD9E4AE-903B-4051-A6FE-2E986F9D5AC0Q36162443-61945D61-1BEF-40DE-BED4-0E44A1911AFDQ36233912-55E66315-4B27-465F-94BA-66A645844FEDQ36315441-4CE69EF9-4226-4AC3-A07B-94CE7ED535C8Q36475386-CDD60822-B447-4169-800C-1F39FEE5C256Q36506765-0F5C0660-AF30-4075-BAF0-0603EF58DD90Q36548179-6B3A6F7B-BFE2-4417-AB95-0395749D8F46Q36724272-602AB8F6-F5B4-4634-96AD-70E965BAB88DQ36811931-0A72ABC1-A85D-491B-9F11-9C0E2103AE51Q38613375-71DB5409-1881-4DD0-A083-346CC8A17848Q39173531-70A993D0-5405-4619-9E8D-2C5C1D5D2BFEQ40076776-D2C3B7F5-346B-4BCA-B571-F2004260C052Q41006917-217664C2-E5FB-4151-B793-12C0BCBC18AAQ42282750-1AB9FCEF-B04B-40B6-A688-36DF423DFB07Q42335670-556F4903-05D4-4A43-BF04-BFE30B837991Q43076222-367A6CF8-018F-4162-A05F-0ACEE51C3FABQ47555946-0DE56BBA-158D-4639-94EB-96497A1578F6Q55092316-EB8ECE7C-2C6E-4505-81A5-D5DD54D6A81E
P2860
The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The breadth of antiviral activ ...... driven by positive selection.
@en
type
label
The breadth of antiviral activ ...... driven by positive selection.
@en
prefLabel
The breadth of antiviral activ ...... driven by positive selection.
@en
P2860
P50
P356
P1433
P1476
The breadth of antiviral activ ...... driven by positive selection.
@en
P2860
P304
11361-11371
P356
10.1128/JVI.05046-11
P407
P577
2011-08-10T00:00:00Z